cost of borrowing. For the impairment loss of loans was 123.45 million baht, a decrease of 15.46 million baht or 11.13%. The decrease was due to monitor the debt collections process closely that support
million baht, a decrease of 2.63 million baht or 1.18%. The decrease was due to additional lower cost of borrowing to support hire purchase loan expansion. For the impairment loss of loans was 73.08 million
early 2019. The SEC will specifically participate in the efficiency assessment of securities regulation and supervision. In revising the rules on approval and disclosure of information by equity issuers
, 2018 with details as follow; unit: million baht Items 6-month period ended 2017 6-month period ended 2018 changes Amount % Amount % Amount % Revenue from sales of goods . . . . . . Cost of sales of goods
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
due to the declining in raw water sales volume and net profit attributable to Equity holders of the parent company was 1,117.52 million Baht, decreased by 103.66 million Baht or 8.49%. Income statement
of cost of goods sold so cause gross loss. Total revenue decreased due to the decrease of sale volume and selling price. Sale volume decrease cause by production volume decrease. Both company and
notable improvement of the performance in terms of revenue and cost-saving compared to last quarter. However, Overall performance on a year-over-year basis was affected by the change in structure of revenue
Power (IRPC-CP Phase 1 and Phase 2) in November 2017, in which GPSC holds 51% equity, allowed the company to expand the electricity generating capacity resulting in an increase in volume of electricity